Takip et
Adam Dicker
Adam Dicker
jefferson.edu üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
American Society of Clinical Oncology statement: a conceptual framework to assess the value of cancer treatment options
LE Schnipper, NE Davidson, DS Wollins, C Tyne, DW Blayney, D Blum, ...
Journal of Clinical Oncology 33 (23), 2563-2577, 2015
9842015
Radiation dose–volume effects in the brain
YR Lawrence, XA Li, I El Naqa, CA Hahn, LB Marks, TE Merchant, ...
International Journal of Radiation Oncology* Biology* Physics 76 (3), S20-S27, 2010
8632010
Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial
R Phillips, WY Shi, M Deek, N Radwan, SJ Lim, ES Antonarakis, SP Rowe, ...
JAMA oncology 6 (5), 650-659, 2020
8092020
Microsurgical inguinal varicocelectomy with delivery of the testis: an artery and lymphatic sparing technique
M Goldstein, BR Gilbert, AP Dicker, J Dwosh, C Gnecco
The Journal of urology 148 (6), 1808-1811, 1992
6601992
Updating the American Society of Clinical Oncology value framework: revisions and reflections in response to comments received
LE Schnipper, NE Davidson, DS Wollins, DW Blayney, AP Dicker, ...
Journal of Clinical Oncology 34 (24), 2925-2934, 2016
6512016
Comparative analysis of prostate‐specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results …
P Grimm, I Billiet, D Bostwick, AP Dicker, S Frank, J Immerzeel, M Keyes, ...
BJU international 109, 22-29, 2012
5752012
Zebrafish: an emerging model system for human disease and drug discovery
G Kari, U Rodeck, AP Dicker
Clinical Pharmacology & Therapeutics 82 (1), 70-80, 2007
5612007
Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer
JJ Farrell, H Elsaleh, M Garcia, R Lai, A Ammar, WF Regine, R Abrams, ...
Gastroenterology 136 (1), 187-195, 2009
5132009
Dihydrofolate reductase as a therapeutic target
BI Schweitzer, AP Dicker, JR Bertino
The FASEB journal 4 (8), 2441-2452, 1990
5021990
Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction
P Wachsberger, R Burd, AP Dicker
Clinical cancer research 9 (6), 1957-1971, 2003
4682003
Dual roles of PARP-1 promote cancer growth and progression
MJ Schiewer, JF Goodwin, S Han, JC Brenner, MA Augello, JL Dean, ...
Cancer discovery 2 (12), 1134-1149, 2012
4612012
A hormone–DNA repair circuit governs the response to genotoxic insult
JF Goodwin, MJ Schiewer, JL Dean, RS Schrecengost, R de Leeuw, ...
Cancer discovery 3 (11), 1254-1271, 2013
3832013
Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas
SE Fogh, DW Andrews, J Glass, W Curran, C Glass, C Champ, JJ Evans, ...
Journal of clinical oncology 28 (18), 3048, 2010
3652010
Differentiation and definition of vascular-targeted therapies
DW Siemann, MC Bibby, GG Dark, AP Dicker, FALM Eskens, ...
Clinical Cancer Research 11 (2), 416-420, 2005
3502005
The meaning of p16ink4a expression in tumors: Functional significance, clinical associations and future developments
AK Witkiewicz, KE Knudsen, AP Dicker, ES Knudsen
Cell cycle 10 (15), 2497-2503, 2011
3162011
Radiotherapy protocol deviations and clinical outcomes: a meta-analysis of cooperative group clinical trials
N Ohri, X Shen, AP Dicker, LA Doyle, AS Harrison, TN Showalter
Journal of the National Cancer Institute 105 (6), 387-393, 2013
2962013
Comparison of antiangiogenic activities using paclitaxel (taxol) and docetaxel (taxotere)
DS Grant, TL Williams, M Zahaczewsky, AP Dicker
International journal of cancer 104 (1), 121-129, 2003
2842003
Telemedicine training in undergraduate medical education: mixed-methods review
S Waseh, AP Dicker
JMIR medical education 5 (1), e12515, 2019
2692019
RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1
JR Prensner, S Zhao, N Erho, M Schipper, MK Iyer, SM Dhanasekaran, ...
The lancet oncology 15 (13), 1469-1480, 2014
2592014
Vimentin is a novel AKT1 target mediating motility and invasion
QS Zhu, K Rosenblatt, KL Huang, G Lahat, R Brobey, S Bolshakov, ...
Oncogene 30 (4), 457-470, 2011
2592011
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20